Abnormal bone and calcium metabolism in patients after stroke

Archives of Physical Medicine and Rehabilitation

Volumn 81, Issue 1, 2000, Pages 117-121

  Sato, Yoshihiro ^a  

^a KURUME UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

Osteoporosis; Rehabilitation; Review; Stroke

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; VITAMIN D;

BONE METABOLISM; BONE MINERAL; CALCIUM BLOOD LEVEL; CALCIUM METABOLISM; HEMIPLEGIA; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; IMMOBILIZATION; OSTEOLYSIS; OSTEOPENIA; REVIEW; STROKE; VITAMIN D DEFICIENCY;

EID: 0033988133     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1053/apmr.2000.0810117     Document Type: Review

References (76)

1. Dietrick JE, Whedon GD, Shorr E. Effects of immobilization upon various metabolic and physiologic functions of normal men. Am J Med 1948;4:3-36.
2. Whedon GD. Shorr E. Metabolic studies of paralytic acute anterior poliomyelitis. II. Alternations in calcium and phosphorus metabolism. J Clin Invest 1957;36:966-81.
3. Minaire P, Meunier P, Edouard C. Bernard J, Courpron P, Bourret J. Quantitative histological data on disuse osteoporosis. Comparison with biological data. Calcif Tissue Res 1974;17:57-73.
4. Claus-Walker J, Spencer WA, Carter RE, Halsted LS, Meiser RH. Campos RJ. Bone metabolism in quadriplegia: dissociation between calciuria and hydroxyprolinuria. Arch Phys Med Rehabil 1975;56:327-32.
5. Bergmann P, Heilpom A, Schoutens A, Patemot J, Tricot A. Longitudinal study of calcium and bone metabolism in paraplegic patients. Paraplegia 1977; 15: 147-59.
6. Naftchi NE, Viau AT, Sell GH, Lowman EW. Mineral metabolism in spinal cord injury. Arch Phys Med Rehabil 1980;61: 139-42.
7. Stewart AF. Adler M. Byers CM, Segre GV. Broadus AE. Calcium homeostasis in immobilization: an example of resorptive hypercalciuria. N Engl J Med 1982;306:1136-40.
8. Chantraine A, Nusgens B, Lapiere CM. Bone remodeling during the development of osteoporosis in paraplegia. Calcif Tissue Int 1986;38:323-7.
9. Biering-Sorensen F, Bohr HH, Schaadt OP. Longitudinal study of bone mineral content in the lumbar spine, the forearm and the lower extremities after spinal cord injury. Eur J Clin Invest 1990;20:330-5.
10. Minaire P. Immobilization osteoporosis: a review. Clin Rheumatol 1989;8 Suppl 2:95-103.
11. Lanyon LE. Functional strains as a determinant for bone remodeling. Calcif Tissue Int 1984;36 Suppl 1:S56-61.
12. Frost HM. Vital biomechanics:' 'proposed general concepts for skeletal adaptations to mechanical usage. Calcif Tissue Int 1988;42: 145-56.
13. Van Ouwenaller C, Uebelhart D. Chantraine A. Bone metabolism in hemiplegic patients. Scand J Rehabil Med 1989;21 : 165-70.
14. Sato Y. Maruoka H. Oizumi K. Kikuvama M. Vitamin D deficiency and osteopenia in the hemiplegic limbs of stroke patients. Stroke 1996;27:2183-7.
15. Sato Y, Fujimatsu Y, Honda Y, Kuno H, Kikuyama M, Oizumi K. Accelerated bone remodeling in the patients with poststroke hemiplegia. J Stroke Cerebrovascular Dis 1998;7:58-62.
16. Sato Y. Fuiimatsu Y. Kikuvama M. Kaii M. Oizumi K. Influence of immobilization on bone mass and bone metabolism in hemiplegic elderly patients with a long-standing stroke. J Neurol Sci 1998; 156: 205-10.
17. Sato Y, Kuno H, Kaji M, Ohshima Y, Asoh T, Oizumi K. Increased bone resorption during the first year after stroke. Stroke 1998;29: 1373-7.
18. Fujimatsu Y. Role of the parathyroid gland on bone mass and metabolism in immobilized stroke patients. Kurume Med J 1998; 45:265-70.
19. Kuno H. Vitamin D status and nonhemiplegic bone mass in patients following stroke. Kurume Med J 1998;46:257-63.
20. Sato Y. Kuno H, Asoh T. Honda Y. Oizumi K. Effect of immobilization on vitamin D status and bone mass in chronically hospitalized, disabled stroke patients. Age Ageing 1999;28:265-9.
21. Nieves J, Cosman F. Herbert J. Shen V. Lindsav R. High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology 1994;44: 1687-92.
22. Cosman F, Nieves J, Komar L, Ferrer G, Herbert J, Formica C, et al. Fracture history and bone loss in patients with MS. Neurology 1998;51:1161-5.
23. Sato Y, Honda Y, Asoh Y, Kikuyama M, Oizumi K. Hypovitaminosis D and decreased bone mineral density in amyotrophic lateral sclerosis. Eur Neurol 1997;37:225-9.
24. Ishizaki F, Harada T, Katayama S, Abe H, Nakamura S. Relationships between osteopenia and clinical characteristics of Parkinson's disease. Mov Disord 1993;8:507- I I.
25. Kao CH, Chen CC, Wang SJ, Chia LG. Yeh SH. Bone mineral density in patients with Parkinson's disease measured by dual photon absorptiometry. Nucl Med Commun 1994; 15: 173-7.
26. Revilla M, de la Sierra G, Aguado F, Varela L, Jimenez-Jimenez FJ, Rico H. Bone mass in Parkinson's disease; a study with three methods. Calcif Tissue Int 1996;58:31 1-5.
27. Taggart H. Crawford V. Reduced bone density of the hip in elderly patients with Parkinson's disease. Age Ageing 1995;24:326-8.
28. Sato Y, Kikuyama M, Oizumi K. High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease. Neurology 1997;49:1273-8.
29. Grisso JA. Kelsey JL. Strom BL. Chiu GY, Maislin G, O'Brien LA. et al. Risk factors for falls as a cause of hip fracture in women. N Engl J Med 1991;324: 1326-3 I.
30. Peszczynski M. The fractured hip in hemiplegic patients. Geriatrics 1957: 12:687-90.
31. Mulley G, Espley AJ. Hip fracture after hemiplegia. Postgrad Med J 1979;55:264-5.
32. Poplingher AR, Pillar T. Hip fracture in stroke patients. Acta Orthop Scand 1985;56:226-7.
33. Hooper G. Internal fixation of fractures of the neck of the femur in hemiplegic patients. Injury 1979;10:281-4.
34. Chiu KY, Pun WK. Luk KDK, Chow SP. A prospective study on hip fractures in patients with previous cerebrovascular accidents. Injury 1992;23:297-9.
35. Hodkinson HM, Brain AT. Unilateral osteoporosis in longstanding hemiplegia in the elderly. J Am Geriatr Soc 1967; 15:59-64.
36. Panin N. Gorday WJ. Paul BJ. Osteoporosis in hemiplegia. Stroke 1971;2:41-7.
37. Denhan MJ. Progressive osteoporosis in hemiplegia. Gerontology 1973;15:361-5.
38. Sato Y, Maruoka H, Honda Y, Asoh T, Fujimatsu Y, Oizumi K. Development osteopenia in the hemiplegic finger in patients with stroke. Eur Neurol 1996;36:278-83.
39. Nafchi NE. Viau AT, Marshall CH. Davis WS. Lowman EW. Bone mineralization in the distal forearm of hemiplegic patients. Arch Phys Med Rehabil 1975;56:487-92.
40. Prince RL, Prince RI. Ho S. Forearm bone loss in hemiplegia: a model for the study of immobilization osteoporosis, J Bone Miner Res 1988;3:305-10.
41. Hamdy RC, Moore SW. Cancellaro VA. Harvill LM. Long-term effects of strokes on bone mass. Am J Phys Med Rehabil 1995;74:351-6.
42. del Puente A. Pappone N, Mandes MG, Mantova D. Scarpa R. Oriente P. Determinant of bone mineral density in immobilization: a study on hemiplegic patients. Osteoporos Int 1996;6:50-4.
43. Tanaka N, Sonoda S, Kondo K. Chino N. Reproducibility of dual-energy X-ray absorptiometry in the upper extremities in stroke patients. Disabil Rehabil 1997;19:523-7.
44. Beadle PC. Sunlight. ozone and vitamin D. Br J Dermatol 1977;97:585-91.
45. Lester E. Skinner RK. Foo AY, Lund B, Sorensen OH. Serum 25-hydroxyvitamin D levels and vitamin D intake in healthy young adults in Britain and Denmark. Scand J Clin Lab Invest 1980;49: 145-50.
46. Komar L. Nieves J, Cosman F. Rubin A, Shen V, Lindsay R. Calcium homeostasis of an elderly population upon admission to a nursing home. J Am Geriatr Soc 1993;41: 1057-64.
47. Parfitt AM. Gallagher JC, Heaney RP, Johnston CC, Neer R, Whedon GD. Vitamin D and bone health in the elderly. Am J Clin Nutr 1982;36: 1014-31.
48. Villareal DT, Civitelli R. Chines A. Avioli LV. Subclinical vitamin D deficiency in osteoporosis. J Clin Endocrinol Metab 1991;72:628-34.
49. Peacock M. Effects of calcium and vitamin D insufficiency on the skeleton. Osteoporos Int 1999;8 Suppl 2:45S-5 I.
50. Matsumoto C, Kushida K, Yamazaki K, Imose K, Imose T. Metacarpal bone mass in normal and osteoporotic Japanese women using computed X-ray densitometry. Calcif Tissue Int 1994;55:324-9.
51. Gloth FM III, Gundberg CM. Hollis SW, Haddad JG. Tobin JD. Vitamin D deficiency in homebound elderly persons. JAMA 1995;274: 1683-6.
52. Fonseca V. Agnew JE. Nag D. Dandona P. Bone density and cortical thickness in nutritional vitamin D deficiency: effect of secondary hyperparathyroidism. Ann Clin Biochem 1988;25: 271-4.
53. Sato Y. Asoh T. Oizumi K. High prevalence of vitamin D deficiency and reduced bone mass in elderly women with Alzheimer's disease. Bone 1998;25:555-7.
54. Sato Y, Oizumi K, Kuno H, Kaji M. Effect of immobilization upon renal synthesis of 1,25-dihydroxyvitamin D in disabled elderly stroke patients. Bone 1999;24:27 I-5.
55. Henke JA. Thompson NW, Kaufer H. Immobilization hypercalcemic crisis. Arch Surg 1975;110:321-3.
56. Hyman LR, Boner G, Thomas JC, Segar WE. Immobilization hypercalcemia. Am J Dis Child 1972; 124:723-7.
57. Lawrence GD. Loeffler RG. Martin LG. Connor TB. Immobilization hypercalcemia. J Bone Joint Surg 1973;55:87-94.
58. Garnero P, Grimaux M, Seguin P, Delmas PD. Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro. J Bone Miner Res 1994;9:255-64.
59. Eriksen EF, Charles P, Melsen F. Mosekilde L. Risteli L, Risteli J. Serum markers of type I collagen formation and degradation in metabolic bone disease: Correlation with bone histomorphometry. J Bone Miner Res 1993;8: 127-32.
60. Holick ME The use and interpretation of assays for vitamin D and its metabolites. J Nutr 1990; 120 Suppl 11: 1464-9.
61. Sinaki M. Exercise and osteoporosis. Arch Phys Med Rehabil 1989;70:220-9.
62. Sato Y, Honda Y, Kuno H, Oizumi K. Long-term oral anticoagulation reduces bone mass in patients with previous hemispheric infarction and nonrheumatic atrial fibrillation. Stroke 1997;28: 2390-4.
63. Sato Y, Tsuru T, Oizumi K, Kaji M. Vitamin K deficiency and osteopenia in disuse-affected limbs of vitamin D-deficient elderly stroke patients. Am J Phys Med Rehabil 1999;78:3 17-22.
64. 3 and calcium supplementation. Stroke 1997;28: 736-9.
65. Sato Y. Honda Y. Kuno H, Oizumi K. Menatetrenone ameliorates osteopenia in disuse-affected limbs of vitamin D- and K-deficient stroke patients. Bone 1998;23:291-6.
66. Dawson-Huehes B. Harris SS. Krall EA. Dallal GE. Effect of calcium and-vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997;337: 670-6.
67. Takenaka M, Nakata M, Tomita M, Nakagawa T, Tsuboi S, Fukase M, et al. Effect of ipriflavone on bone changes induced by calcium restricted, vitamin D deficient diet in rats. Endocrinol Jon 1986;33: 23-7.
68. Irie K, Nakamura H, Mizoguchi J, Nushimura A, Oka M. Tsuda M, et al. Effect of ipriflavone and estrogen on bone changes induced by immobilization in rats [in Japanese; abstract]. J Bone Miner Metab 1994; 12:350.
69. Sato Y, Kuno H, Kaii M, Saruwatari N, Oizumi K. Effect of ipriflavone on bone in elderly hemiplegic stroke patients with hypovitaminosis D. Am J Phys Med Rehabil 1999;78:457-63.
70. Tilyard MW, Spears GFS, Thomson J, Dovey S. Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 1992;326:357-62.
71. 2D. Am J Clin Nutr 1990;52:70 1-6.
72. Liberman UA, Weiss ST, Bröll J. Minne HW, Quan H, Bell NH, et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 1995;333: 1437-43.
73. Karpf DB, Shapiro DR. Seeman E, Ensrud KE, Johnston CC, Adami S, et al. Prevention of nonvertebral fractures by alendronate. a meta-analysis. JAMA 1997;277:1159-64.
74. Orr-Walker B, Wattie DJ. Evans MC, Reid IR. Effects of prolonged bisphosphonate therapy and its discontinuation on bone mineral density in post-menopausal osteoporosis. Clin Endocrinol 1997;46:87-92.
75. Cummings SR, Black DM, Thompson DE, Applegate WB, Barrett-Connor E, Musliner TA, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures. JAMA 1998;280:2077-82.
76. Naesson T, Persson I, Adami HO, Bergstrom R, Bergkvist L. Hormone replacement therapy and the risk for first hip fracture. A prospective, population-based cohort study. Ann Intern Med 1990;113:95-103.